EventHealthOctober 13, 2026

Science Corporation implants PRIMA vision chip in first Stargardt patient

Read original source →techcrunch.com

The first Stargardt disease patient received the PRIMA implant in May at Sydney Eye Hospital in Australia. Stargardt affects roughly 150,000 people worldwide; PRIMA is already commercially available in Europe for geographic atrophy.

People · Max Hodak

1 source

More stories today

Open the live feed